Multimodal treatment of colon and rectal cancers: Quality parameters;Multimodale therapie von kolon- und rektumkarzinomen: Qualitä tsparameter

Viszeralmedizin: Gastrointestinal Medicine and Surgery

Volumn 25, Issue 2, 2009, Pages 105-117

  Link, Karl Heinrich ^a,c   Kornmann, Marko ^b   Mann, Markus ^c   Bittner, Reinhard ^a  

^a Rektumkarzinom ^*

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c Asklepios Paulinen Klinik   (Germany)

Author keywords

Colon cancer; Multimodal treatment; Quality parameters; Rectal cancer

Indexed keywords

CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER THERAPY; COLON CARCINOMA; HUMAN; MEDICAL CARE; MEDICAL EDUCATION; MEDICAL SPECIALIST; MULTIMODALITY CANCER THERAPY; QUALITATIVE ANALYSIS; RECTUM CARCINOMA; REVIEW;

EID: 71749112392     PISSN: 16626664     EISSN: 16626672     Source Type: Journal    
DOI: 10.1159/000225409     Document Type: Review

References (85)

1. Link KH, Mörschel M, Sagban TA, Appell V, Holtappels M, Tischbirek K: Chirurgie und multimodale Therapie des Kolonkarzinoms: Evidenzbasis? Chir Gastroenterol 2004;20:39-54.
2. Link KH, Sagban TA, Morschel M, Tischbirek K, Holtappels M, Apell V, Zayed K, Kornmann M, Staib L: Colon cancer: survival after curative surgery. Langenbecks Arch Surg 2005;390:83-93.
3. Link KH, Staib L, Kreuser ED, Beger HG; for the Forschungsgruppe Onkologie Gastrointestinaler Tumoren (FOGT): Adjuvant treatment of colon and rectal cancer: impact of chemotherapy, radiotherapy, and immunotherapy on routine postsurgical patient management. RRCR 1996;142:311-352.
4. Robert Koch Institut: Krebs in Deutschland, 2003- 2004, Häufigkeiten und Trends, 6. Aufl. Berlin, Robert Koch-Institut, 2008, pp 11-14. www.rki.de/ cln-091/nn-205770/DE/Content/GBE/Gesundheitsberichterstattung/ GBEDownloadsB/KID2008,temp lateId=raw,property=publicationFile.pdf/KID2008.pdf.
5. Schmiegel W, Reinacher-Schick A, Arnold U, Graeven U, Heinemann V, Porschen R, Riemann J, Rödel C, Sauer R, Wieser M, Schmitt W, Schmoll H-J, Seufferlein T, Kopp I, Pox C: S3-Leitlinie «Kolorektales Karzinom» - Aktualisierung 2008. Z Gastroenterol 2008;46;799-840.
6. Hermanek P, Mansmann U, Altendorf-Hofmann A, Hermanek P Jr, Riedl S, Staimmer D; für die Studiengruppe Kolorektales Karzinom SGKRK: Vergleichende Beurteilung der onkologischen Ergebnisqualität beim colorectalen Carcinom. Klinikvergleiche anhand von Surogatendpunkten? Chirurg 1999;70:407-414.
7. Hermanek P, Wiebelt H, Staimmer D, Riedl S: Prognostic factors of rectum carcinoma - experience of the German Multicentre Study SGCRC. German Study Group Colo-Rectal Carcinoma. Tumori 1995;81(3 suppl):60-64.
8. Link KH, Staib L, Baumann W, Redenbacher M, Sander S, Henne-Bruns D, Kornmann M: Modulation of adjuvant 5-FU treatment by folinic acid and interferon-alpha in colon and rectal cancer: Comparison of two phase-III trials including 1652 patients. Eur J Surg Oncol 2006;32. 13th Congress of the EJSO.
9. Marusch F, Koch A, Schmidt U, Pross M, Gastinger I, Lippert H: Hospital caseload and the results achieved in patients with rectal cancer. Br J Surg 2001;88:1397-1402.
10. Marusch F, Koch A, Schmidt U, Zippel R, Lehmann M, Czarnetzki HD, Knoop M, Geissler S, Pross M, Gastinger I, Lippert H: Effect of caseload on the short-term outcome of colon surgery: Results of a multicenter study. Int J Colorectal Dis 2001;16;362-369.
11. Matzel KE, Stadelmaier U, Hohenfellner M, Hohenberger W: Chronic sacral spinal nerve stimulation for fecal incontinence: long-term results with foramen and cuff electrodes. Dis Colon Rectum 2001;44:59-66.
12. Staib L, Link KH, Blatz A, Beger HG: Surgery of colorectal cancer: surgical morbidity and five- and ten-year results in 2004 patients - monoinstitutional experience. World J Surg 2002;26:59-66.
13. Bruch HP, Schwandner O, Sterk P, Schiedeck THK: Operative Therapie des Rektumkarzinoms. Aktuelle Entwicklungen unter besonderer Berücksichtigung sphinktererhaltender und laparoskopischer Eingriffe. Onkologe 2001;7:381-390.
14. Bulow S, Christensen IJ, Harling H, Kronborg O, Fenger C, Nielsen HJ; Danish TME Study Group and RANX05 Colorectal Cancer Study Group: Recurrence and survival after mesorectal excision for rectal cancer. Br J Surg 2003;90:874-880.
15. Enker WE: Potency, cure, and local control in the operative treatment of rectal cancer. Arch Surg 1992; 127:1396-1401.
16. Heald RJ, Karanjia ND: Results of radical surgery for rectal cancer. World J Surg 1992;16:848-857.
17. Lippert H, Gastinger I: Versorgung von Patienten mit Rektumkarzinomen in Deutschland. Dtsch Arztebl 2006;103:2704-2709.
18. MacFarlane JK, Ryall RD, Heald RJ: Mesorectal excision for rectal cancer. Lancet 1993;341:457-460.
19. Ridgway PF, Darzi AW: The role of total mesorectal excision in the management of rectal cancer. Cancer Control 2003;10:205-211.
20. Pahlman L, Gunnarsson, U Karlbom U: The influence on treatment outcome of structuring rectal cancer care. Eur J Surg Oncol 2005;31:645-649.
21. Greene FL, Stewart AK, Norton HJ: A new TNM staging strategy for node-positive (stage III) colon cancer: An analysis of 50,042 patients. Ann Surg 2002;236;416-421.
22. O'Connell JB, Maggard MA, Ko CY: Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004;96:1420-1425.
23. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP: American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer 2000;88:1739-1757. (Pubitemid 30183160)
24. Willett CG, Badizadegan K, Ancukiewicz M, Shellito PC: Prognostic factors in stage T3N0 rectal cancer: do all patients require postoperative pelvic irradiation and chemotherapy? Dis Colon Rectum 1999;42:167-173.
25. Adam IJ, Mohamdee MO, Martin IG, Scott N, Finan PJ, Johnston D, Dixon MF, Quirke P: Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 1994;344:707-711.
26. Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP, Abbott CR, Scott N, Finan PJ, Johnston D, Quirke P: Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002;235:449-457.
27. Nagtegaal ID, van de Velde CJ, van der Worp E ,Kapiteijn E, Quirke P, van Krieken JH; Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group: Macroscopic evaluation of rectal cancer resection specimen: Clinical significance of the pathologist in quality control. J Clin Oncol 2002; 20:1729-1734.
28. Stocchi L, Nelson H, Sargent DJ, O'Connell MJ, Tepper JE, Krook JE, Beart R; the North Central Cancer Research Group: Impact of surgical and pathologic variables in rectal cancer: A United States community and cooperative group report. J Clin Oncol 2001;19:3895-3902.
29. Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, Soreide O: Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002;89:327-334.
30. Beets-Tan RG, Lettinga T, Beets GL: Pre-operative imaging of rectal cancer and its impact on surgical performance and treatment outcome. Eur J Surg Oncol 2005;31;681-688.
31. Strassburg J, Lewin A, Ludwig K, Kilian L, Linke J, Loy V, Knuth P, Puttcher O, Ruehl U, Stockmann F, Hackenthal M, Hopfenmuller W, Huppertz A: Optimised surgery (so-called TME surgery) and high-resolution MRI in the planning of treatment of rectal carcinoma. Langenbecks Arch Surg 2007;392:179-188.
32. Siewert JR: Laudatio Friedrich Stelzner zum 80. Geburtstag. Deutsche Gesellschaft für Chirurgie - Mitteilungen 1/02:40-43.
33. Marusch F, Koch A, Schmidt U, Meyer L, Steinert R, Pross M, Kockerling F, Bauer H, Schonleben K, Halbfass HJ, Scheele J, Gastinger I, Lippert H: Importance of rectal extirpation for the therapy concept of low rectal cancers. Chirurg 2003;74;341-351.
34. Holm T: Evidence of surgical training and case load on outcome in rectal cancer surgery. The Stockholm experience. Vortrag beim 123. Kongress Deutsche Gesellschaft für Chirurgie, Mai 2006.
35. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ; Dutch Colorectal Cancer Group: Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345:638-646. (Pubitemid 34936565)
36. Enker WE: Total mesorectal excision - the new golden standard of surgery for rectal cancer. Ann Med 1997;29:127-133.
37. Nesbakken A, Nygaard K, Lunde OC: Mesorectal excision for rectal cancer: Functional outcome after low anterior resection and colorectal anastomosis without a reservoir. Colorectal Dis 2002;4:172-176.
38. Rosen HR, Schiessel R: Anterior rectum resection. Chirurg 1996;67:99-109.
39. Bonjer HJ, Hop WC, Nelson H, Sargent DJ, Lacy AM, Castells A, Guillou PJ, Thorpe H, Brown J, Delgado S, Kuhrij E, Haglind E, Pahlman L: Laparoscopically assisted vs open colectomy for colon cancer: A meta-analysis. Arch Surg 2007;142;298-303.
40. Köckerling F: Kommentar auf der Jahrestagung der SGKRK. Hannover, 24 Februar 2007.
41. Ptok H, Steinert R, Meyer F, Kroll KP, Scheele C, Kockerling F, Gastinger I, Lippert H: Long-term oncological results after laparoscopic, converted and primary open procedures for rectal carcinoma. Results of a multicenter observational study. Chirurg 2006;77;709-717.
42. Becker H: Kritischer Kommentar: Evidenz und Erfahrung - Widerspruch oder notwendige Ergänzung? Kongress der DGCH/DGVC, Berlin, 2008.
43. McArdle CS, Hole D: Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ 1991;302:1501-1505.
44. Hermanek P, Wiebelt H, et al.: Langzeitergebnisse der chirurgischen Therapie des Kolonkarzinoms (Ergebnisse der Studiengruppe Kolorektales Karzinom). Chirurg 1994;65:287-297.
45. Billingsley KG, Morris AM, Dominitz JA, Matthews B, Dobie S, Barlow W, Wright GE, Baldwin LM: Surgeon and hospital characteristics as predictors of major adverse outcomes following colon cancer surgery: understanding the volume-outcome relationship. Arch Surg 2007;142;23-31.
46. McArdle CS, Hole DJ: Influence of volume and specialization on survival following surgery for colorectal cancer. Br J Surg 2004;91;610-617.
47. Birkmeyer JD, Siewers AE, Finlayson E, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE: Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346:1128-1137.
48. Hermanek P, Hohenberger W: The importance of volume in colorectal cancer surgery. Eur J Surg Oncol 1996;22;213-215.
49. Martling A, Cedermark B, Johansson H, Rutqvist LE, Holm T: The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg 2002;89: 1008-1013.
50. Holm T, Johansson H, Cedermark B, Ekelund G, Rutqvist LE: Influence of hospital- and surgeon-related factors on outcome after treatment of rectal cancer with or without preoperative radiotherapy. Br J Surg 1997;84;657-663.
51. Harmon JW, Tang DG, Gordon TA, Bowman HM, Choti MA, Kaufman HS, Bender JS, Duncan MD, Magnuson TH, Lillemoe KD, Cameron JL: Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg 1999;230:404-411.
52. Smith JA, King PM, Lane RH, Thompson MR: Evidence of the effect of 'specialization' on the management, surgical outcome and survival from colorectal cancer in Wessex. Br J Surg 2003;90:583-592.
53. Mack LA, Temple WJ: Education is the key to quality of surgery for rectal cancer. Eur J Surg Oncol 2005;31:636-644.
54. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B: Effect of a surgical training programme on outcome of rectal cancer in the county of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000;356:93-96.
55. Kapiteijn E, Putter H, van de Velde CJ: Impact of the introduction and training of total mesorectal excision on recurrence and survival in rectal cancer in The Netherlands. Br J Surg 2002;89:1142-1149.
56. Hermanek P, Heald RJ: Pre-operative radiotherapy for rectal carcinoma? Has the case really been made for short course pre-operative radiotherapy if surgical standards for rectal carcinoma are optimal? Colorectal Dis 2004;6:10-14.
57. Köckerling F, Reymond MA, Altendorf-Hofmann A, Dworak O, Hohenberger W: Influence of surgery on metachronous distant metastases and survival in rectal cancer. J Clin Oncol 1998;16:324-329. (Pubitemid 28041616)
58. Porter GA, Soskolne CL, Yakimets WW, Newman SC: Surgeon-related factors and outcome in rectal cancer. Ann Surg 1998;227;157-167.
59. Smedh K, Olsson L, Johansson H, Aberg C, Andersson M: Reduction of postoperative morbidity and mortality in patients with rectal cancer following the introduction of a colorectal unit. Br J Surg 2001;88:273-277.
60. Singh KK, Aitken RJ: Outcome in patients with colorectal cancer managed by surgical trainees. Br J Surg 1999;86:1332-1336.
61. Peeters KC, van de Velde CJH: Surgical quality assurance in rectal cancer treatment: The key to improved outcome. Eur J Surg Oncol 2005;31:630-635.
62. Urbach DR, Baxter NN: Does it matter what a hospital is 'high volume' for? Specificity of hospital volume-outcome associations for surgical procedures: Analysis of administrative data. Qual Saf Health Care 2004;13:379-383.
63. Urbach DR, Bell CM, Austin PC: Differences in operative mortality between high- and low-volume hospitals in Ontario for 5 major surgical procedures: estimating the number of lives potentially saved through regionalization. CMAJ 2003;168:1409-1414.
64. Ohmann C: Quantität und Behandlungsergebnisse - ist ein Parameter zur Bewertung ausreichend? 125. Kongress der Deutschen Gesellschaft für Chirurgie, Berlin, April 2008.
65. Wein A, Lehnert T, Liersch T, Franke F, Wakker R, Hahn EG, Hohenberger W: Quality controlled surgery in adjuvant treatment of colon cancer UICC III: Intact - a multicenter phase III trial. J Cancer Res Clin Onc 2002:12(suppl 1):78.
66. Kornmann M, Formentini A, Ette C, Henne-Bruns D, Kron M, Sander S, Baumann W, Kreuser ED, Staib L, Link KH: Prognostic factors influencing the survival of patients with colon cancer receiving adjuvant 5-FU treatment. Eur J Surg Oncol 2008;34: 1316-1321.
67. Link KH, Kornmann M, Staib L, Redenbacher M, Kron M, Beger HG: Increase of survival benefit in advanced resectable colon cancer by extent of adjuvant treatment: Results of a randomized trial comparing modulation of 5-FU + levamisole with folinic acid or with interferon-alpha. Ann Surg 2005;242: 178-187.
68. Kornmann M, Schwabe W, Sander S, Kron M, Sträter J, Polat S, Kettner E, et al.: Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-flurouracil. Clin Canc Res 2003;9:4116-4124.
69. Ottevanger PB, De Mulder PH: The quality of chemotherapy and its quality assurance. Eur J Surg Oncol 2005;31:656-666.
70. Poortmans PM, Davis JB, Ataman F, Bernier J, Horiot JC: The quality assurance programme of the Radiotherapy Group of the European Organisation for Research and Treatment of Cancer: past, present and future. Eur J Surg Oncol 2005;31:667-674.
71. Pichlmaier H, Hossfeld DK, Sauer R: Konsensus der CAO, AIO und ARO zur adjuvanten Therapie bei Kolon-und Rektumkarzinom vom 11.3.1994. Onkologie 1994;17:291-293.
72. Schrag D, Gelfand SE, Bach PB, Guillem J, Minsky BD, Begg, CB: Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results - Medicare. J Clin Oncol 2001;19;3712-3718.
73. Kornmann M, Staib L, Sander S, Henne-Bruns D, Link KH: Prognostic factors influencing the outcome of 1652 patients with colon or rectal cancer receiving adjuvant 5-FU-based chemotherapy. Eur J Surg Oncol 2006:32. 13th Congress of the EJSO.
74. Arkenau HT, Bermann A, Rettig K, Strohmeyer G, Porschen R: 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial. Ann Oncol 14;2003; 395-399.
75. Porzsolt F, Wirth A, Mayer-Steinacker R, Voigt W, Heymer B, Link KH, Schulte M, Röttinger EM: Qualitätssicherung in der Onkologie. Münch Med Wochenschr 1994;136:371-376.
76. Finlayson E, Nelson H: Predicting quality in surgery. Br J Surg 2005;92:129-130.
77. Beckmann, Matthias W. et al.: Onkologie Dreistufenmodell optimiert Behandlung unter Kostendeckung Wie die künftigen Strukturen der onkologischen Versorgung in Deutschland aussehen sollten. Dtsch Arztebl 2007;104: A-3004 / B-2644 / C-2562.
78. Willis S, Schumpelick V: Rektumkarzinom; in Siewert JR, Rothmund M, Schumpelick V (Hrsg): Praxis der Viszeralchirurgie, 2. Aufl. Heidelberg, Springer, 2006, pp 642-660.
79. Hannan EL, O'Donnell JF, Kilburn H, Bernard HR, Yazici A: Investigation of the relationship between volume and mortality for surgical procedures performed in New York state hospitals. JAMA 1989;262:503-510.
80. Kelly JV, Hellinger FJ: Physician and hospital factors associated with mortality of surgical patients. Med Care 1986;24:785-800.
81. Schrag D, Cramer LD, Bach PB, Cohen AM, Warren JL, Begg CB: Influence of hospital procedure volume on outcomes following surgery for colon cancer. JAMA 2000;284:3028-3035.
82. Hodgson DC, Zhang W, et al.: Relation of hospital volume to colostomy rates and survival for patients with rectal cancer. J Natl Cancer Inst 2003;95:708-716.
83. Meyerhardt JA, Tepper JE, Niedzwiecki D, Hollis DR, Schrag D, Ayanian JZ, O'Connell MJ, Weeks JC, Mayer RJ, Willett CG, Macdonald JS, Benson AB III, Fuchs CS: Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: Findings from the Intergroup 0114 Study. J Clin Oncol 2004;22:166-174.
84. Simunovic M, To T, Baxter N, Balshem A, Ross E, Cohen Z, McLeod R, Engstrom P, Sigurdson E: Hospital procedure volume and teaching status do not influence treatment and outcome measures of rectal cancer surgery in a large general population. J Gastrointest Surg 2000;4:324-330.
85. Parry JM, Collins S, Mathers J, Scott NA, Woodman CB: Influence of volume of work on the outcome of treatment for patients with colorectal cancer. Br J Surg 1999;86:475-481.